Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial

PURPOSE: Local/systemic symptoms during cancer therapy may be exacerbated by dysregulated inflammation and its downstream toxic effects. Minocycline can suppress proinflammatory cytokine release; therefore, we investigated its potential to reduce patient-reported symptom severity during radiotherapy...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Support Care Cancer
Hlavní autoři: Gunn, G. Brandon, Mendoza, Tito R., Garden, Adam S., Wang, Xin Shelley, Shi, Qiuling, Morrison, William H., Frank, Steven J., Phan, Jack, Fuller, Clifton D., Chambers, Mark S., Hanna, Ehab Y., Lu, Charles, Rosenthal, David I., Cleeland, Charles S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470188/
https://ncbi.nlm.nih.gov/pubmed/31037378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-04791-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky